These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 9042653)

  • 21. Morphological and cellular basis for airflow limitation in smokers.
    Saetta M; Finkelstein R; Cosio MG
    Eur Respir J; 1994 Aug; 7(8):1505-15. PubMed ID: 7957838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of lung surfactant in respiratory disease: current knowledge in large animal medicine.
    Christmann U; Buechner-Maxwell VA; Witonsky SG; Hite RD
    J Vet Intern Med; 2009; 23(2):227-42. PubMed ID: 19192153
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microscale distribution and dynamic surface tension of pulmonary surfactant normalize the recruitment of asymmetric bifurcating airways.
    Yamaguchi E; Nolan LP; Gaver DP
    J Appl Physiol (1985); 2017 May; 122(5):1167-1178. PubMed ID: 28057816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Airway wall liquid. Sources and role as an amplifier of bronchoconstriction.
    Yager D; Kamm RD; Drazen JM
    Chest; 1995 Mar; 107(3 Suppl):105S-110S. PubMed ID: 7874985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary surfactant in the airway physiology: a direct relaxing effect on the smooth muscle.
    Calkovska A; Uhliarova B; Joskova M; Franova S; Kolomaznik M; Calkovsky V; Smolarova S
    Respir Physiol Neurobiol; 2015 Apr; 209():95-105. PubMed ID: 25583659
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pulmonary surfactant in health and human lung diseases: state of the art.
    Griese M
    Eur Respir J; 1999 Jun; 13(6):1455-76. PubMed ID: 10445627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ventilation and secretion of pulmonary surfactant.
    Wirtz H; Schmidt M
    Clin Investig; 1992 Jan; 70(1):3-13. PubMed ID: 1600328
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Remodeling in asthma and chronic obstructive lung disease.
    Jeffery PK
    Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 2):S28-38. PubMed ID: 11734464
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cartilaginous airway dimensions and airflow obstruction in human lungs.
    Tiddens HA; Paré PD; Hogg JC; Hop WC; Lambert R; de Jongste JC
    Am J Respir Crit Care Med; 1995 Jul; 152(1):260-6. PubMed ID: 7599833
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surfactant function affected by airway inflammation and cooling: possible impact on exercise-induced asthma.
    Enhorning G; Hohlfeld J; Krug N; Lema G; Welliver RC
    Eur Respir J; 2000 Mar; 15(3):532-8. PubMed ID: 10759448
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the causes of lung hyperinflation during bronchoconstriction.
    Pellegrino R; Brusasco V
    Eur Respir J; 1997 Feb; 10(2):468-75. PubMed ID: 9042651
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitric oxide and airway disease.
    Barnes PJ
    Ann Med; 1995 Jun; 27(3):389-93. PubMed ID: 7546629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peripheral airway smooth muscle mechanics in obstructive airways disease.
    Opazo Saez AM; Seow CY; Paré PD
    Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):910-7. PubMed ID: 10712342
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The relation between morphologic and functional airway changes in bronchial asthma].
    Kips JC
    Verh K Acad Geneeskd Belg; 2003; 65(4):247-65; discussion 265-9. PubMed ID: 14534940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Chronobiology of the bronchial system].
    Marek W
    Pneumologie; 1997 Apr; 51 Suppl 2():430-9. PubMed ID: 9244891
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical aspects of peripheral airway diseases in chronic obstructive pulmonary disease].
    Sasaki H
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 May; 27(5):550-5. PubMed ID: 2615094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interaction between parenchyma and airways in chronic obstructive pulmonary disease and in asthma.
    Pride NB; Ingram RH; Lim TK
    Am Rev Respir Dis; 1991 Jun; 143(6):1446-9. PubMed ID: 2048835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of mucus in chronic obstructive pulmonary disease.
    Wanner A
    Chest; 1990 Feb; 97(2 Suppl):11S-15S. PubMed ID: 2404706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of surfactant in asthma.
    Hohlfeld JM
    Respir Res; 2002; 3(1):4. PubMed ID: 11806839
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysfunction of pulmonary surfactant in asthmatics after segmental allergen challenge.
    Hohlfeld JM; Ahlf K; Enhorning G; Balke K; Erpenbeck VJ; Petschallies J; Hoymann HG; Fabel H; Krug N
    Am J Respir Crit Care Med; 1999 Jun; 159(6):1803-9. PubMed ID: 10351922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.